Username Password
S&P 500: 1,358.84 Change: -0.18%

CURIS INC (CRIS)

Overview
Price 4.50
Price Change Today -$0.01 (-0.22%)
P&P rating Rating: 3
Zacks Rank 3 - HOLD
Open Price $4.49
Previous Close $4.51
Daily Range $4.40 - $4.62
52-Week Range $2.70 - $5.65
Volume 637,578
chart
Curis, Inc. is a therapeutic drug development company focusing on cancer, neurological and dermatological disease indications, with technologies that utilize regulatory pathways that control repair and regeneration. Curis' product development involves the use of small molecules or proteins to modulate these pathways. The company has successfully used this technology and product development approach to produce several promising drug product candidates in the fields of cancer, neurological disorders, hair growth, kidney and other diseases, as well as cardiovascular disease.
Other Resources for CRIS
zacks.com
Commentary
Zacks Blog: Roche Brings Another Drug to Market
February 1, 2012
Zacks Blog: Roche Eyes Cancer Drug Approval
November 14, 2011
Zacks Blog: Roche Seeks Approval for BCC Drug
September 13, 2011
Zacks Blog: Positive Data on Roche's BCC Drug
June 21, 2011
Zacks Blog: Pipeline Progress at Roche
March 22, 2011
Curis, Inc. is a therapeutic drug development company focusing on cancer, neurological and dermatological disease indications, with technologies that utilize regulatory pathways that control repair and regeneration. Curis' product development involves the use of small molecules or proteins to modulate these pathways. The company has successfully used this technology and product development approach to produce several promising drug product candidates in the fields of cancer, neurological disorders, hair growth, kidney and other diseases, as well as cardiovascular disease.
 
Brokerage Analyst Recommendations
8 Brokerage Firms Covering CRIS
 
  
Strong Buy
7
Buy
1
Hold
0
Sell
0
Strong Sell
0
Average Broker Recommendation (ABR): 1.13
 
CRIS Ratings:BUY  SELL  HOLD
CRIS Consensus Forecasts
Rate this Stock!
You haven't rated this stock yet!

What The Community Thinks

Total Players

13 Buy
1 Sell
 
Top Buy Analysis
BUY: CRIS Rating: 3
Company: CURIS INC.
Points: -5.90
Start Price: $4.79
Start Date: 02/15/2012 8:39 PM
hook2412
hook2412
P&P Score: 99.17
Recs:
small biotech/pharma co takeover candidate because big pharma is losing patents on blockbuster products the voids needs to be filled and this seem to be a trend buying small to mid cap companies with interesting products potential

Comments: 0 | Comment


Top Sell Analysis
SELL: CRIS Rating: 3
Company: CURIS INC.
Points: 18.43
Start Price: $5.47
Start Date: 02/07/2012 11:49 AM
JoeJustJoe
JoeJustJoe
P&P Score: 99.75
Recs:
The 5.65 rampola last week wuz already a CT...todaze 5.43 high is a CT at the lower high. 3J

Comments: 2 | Comment

Blog Posts
User User Score Date Title Comments Last Comment
Zacks_Analysts
0.00 02/01/12 Roche Brings Another Drug to Market - Analyst Blog 0
Zacks_Analysts
0.00 11/14/11 Roche Eyes Cancer Drug Approval - Analyst Blog 0
Zacks_Analysts
0.00 09/13/11 Roche Seeks Approval for BCC Drug - Analyst Blog 0
Zacks_Analysts
0.00 06/21/11 Positive Data on Roche's BCC Drug - Analyst Blog 0
Zacks_Analysts
0.00 03/22/11 Pipeline Progress at Roche - Analyst Blog 0
Commentary
BUY: CURIS INC. (CRIS) Rating: 3
Start Price: $4.79
Points: -5.90
Created: 02/15/2012
small biotech/pharma co takeover candidate because big pharma is losing patents on blockbuster products the voids needs to be filled and this seem to be a trend buying small to mid cap companies with interesting products potential

Comments: 0 | Comment

Recs:
 
SELL: CURIS INC. (CRIS) Rating: 3
Start Price: $5.47
Points: +18.43
Created: 02/07/2012
The 5.65 rampola last week wuz already a CT...todaze 5.43 high is a CT at the lower high. 3J

Comments: 2 | Comment

Recs:
 
BUY: CURIS INC. (CRIS) Rating: 3
Start Price: $3.90
Points: +5.74
Created: 12/12/2011
suspect more upside

Comments: 0 | Comment

Recs:
 
BUY: CURIS INC. (CRIS) Rating: 3
Start Price: $3.28
Points: +34.07
Created: 03/27/2011
positive results from latest cancer trials

Comments: 0 | Comment

Recs:
 
BUY: CURIS INC. (CRIS) Rating: 3
Start Price: $3.29
Points: +17.43
Created: 05/15/2010
an orally-administered small molecule Hedgehog pathway inhibitor to stop cancer

Comments: 0 | Comment

Recs:
 
BUY: CURIS INC. (CRIS) Rating: 3
Start Price: $2.40
Points: +52.47
Created: 09/03/2009
Breaking out and momentum is good

Comments: 0 | Comment

Recs:
 
BUY: CURIS INC. (CRIS) Rating: 3
Start Price: $4.43
Points: -6.55
Created: 12/22/2011
d yn

Comments: 0 | Comment

Recs:
 
BUY: CURIS INC. (CRIS) Rating: 3
Start Price: $2.68
Points: +75.72
Created: 01/01/2008

Comments: 0 | Comment

Recs:
 
BUY: CURIS INC. (CRIS) Rating: 3
Start Price: $2.61
Points: +80.23
Created: 01/01/2008

Comments: 0 | Comment

Recs:
 
BUY: CURIS INC. (CRIS) Rating: 3
Start Price: $2.51
Points: +87.12
Created: 01/01/2008

Comments: 0 | Comment

Recs:
 
Pages: [ 1 ]  2  >>
Picks
Username P&P Score Call Time Frame Start Date Start Price Today (change) Stock Gain S&P Gain Points Analysis
hook2412 99.17 BUY One to Three Months 02/15/2012 $4.79 $4.51
(+0.45%)
-5.85% +0.06% -5.90 view
JoeJustJoe 99.75 SELL Six Months to a Year 02/07/2012 $5.47 $4.51
(+0.45%)
-17.55% +0.88% +18.43 view
Yade 99.86 BUY One to Three Years 12/22/2011 $4.43 $4.51
(+0.45%)
+1.81% +8.36% -6.55 view
JDShots 0.22 BUY One to Three Months 12/12/2011 $3.90 $4.51
(+0.45%)
+15.64% +9.90% +5.74 view
pluyendyk 2.27 BUY One to Three Months 03/27/2011 $3.28 $4.51
(+0.45%)
+37.50% +3.43% +34.07 view
mdmoney 98.51 BUY Three to Six Months 05/15/2010 $3.29 $4.51
(+0.45%)
+37.08% +19.65% +17.43 view
OnIslandTrader 0.30 BUY One to Three Months 09/03/2009 $2.40 $4.51
(+0.45%)
+87.92% +35.45% +52.47 view
abgroove 72.93 BUY Six Months to a Year 01/01/2008 $2.68 $4.51
(+0.45%)
+68.28% -7.43% +75.72
Kien 75.73 BUY Six Months to a Year 01/01/2008 $2.61 $4.51
(+0.45%)
+72.80% -7.43% +80.23
GOLDENGOD BUY Six Months to a Year 01/01/2008 $2.51 $4.51
(+0.45%)
+79.68% -7.43% +87.12
Pages: [ 1 ]  2  >>
Sponsored Links